Tag: Therapix Biosciences

Israeli Cannabinoid Biotech Therapix IPOs on NASDAQ

Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing TEL AVIV, Israel, March 22, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a...
- March 22nd, 2017 at 3:14 pm

Therapix Extends Ultra-Low Dose Cannabinoid Development Program

Therapix Biosciences Provides Portfolio Update TEL AVIV, Israel, January 11, 2017 /PRNewswire/ — Therapix Biosciences (OTCQB: THXBY) (TASE: THXBY.TA), a clinical-stage pharma company specializing in the development of cannabinoid-based...
- January 12th, 2017 at 2:56 pm